Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

View:
Post by palinc2000 on Jan 14, 2022 3:52pm

4 pm PR

It almost feels that way.....I hope I am wrong but the trading feels that way

Seeme like the re is a target closing price 
Friday afternoon jitters!!!
Comment by houbahop on Jan 14, 2022 3:56pm
You can bet they will print another 20m shares shortly.
Comment by SABBOBCAT on Jan 14, 2022 4:03pm
So unlike last year, they have not released any preliminary financials. TH can't raise without making that info public, so it stands to reason there isnt a financing coming before mid Feb. However, if a prelim PR hits I would run for the hills. 
Comment by houbahop on Jan 14, 2022 4:47pm
From November 23, 2021 PR: Theratechnologies Announces Renewal of Shelf Prospectus and Registration Statement; At-The-Market Facility to be Extended "...provide for the potential offering in Canada and the United States of up to an aggregate of US $150,000,000 of common shares, preferred shares, subscription receipts, warrants, debt securities and units from time to time over a 25-month ...more  
Comment by Wino115 on Jan 14, 2022 10:04pm
If capital is raised prior to trial news and at a low price, we won't be the only disgusted shareholders. Soleus's two largest holdings have been crushed -- Bioatla is down form $40 to $12 and C3 is down from $50 to 30.  They will not want to stump up more money and they will want to see this company maximize the share price, not crush it. They are now on our side of the equation ...more  
Comment by LouisW on Jan 15, 2022 1:20am
Interestingly, Soleus sold both BCAB and CCCC, two of Soleus's largest foldings, but not THTX. Indeed, they are with us.
Comment by realitycheck4u on Jan 15, 2022 2:34am
This post has been removed in accordance with Community Policy
Comment by palinc2000 on Jan 15, 2022 10:56am
  Cash is king but unfortunately all the cash on hand is owed to holders of the convert with a shortfall of over 20 million !! Nash clinical trial cost is over 100 million and Sort 1 platform in the tens of millions at a minimum.Add to that cash for working capital ...... The best case scenario was a partnering deal for Nash ,,, fantastic results in Phase 1 with a SP north of 10Usd ...more  
Comment by Bucknelly21 on Jan 15, 2022 12:54pm
So palinic was Paul the person you thought? 
Comment by SPCEO1 on Jan 15, 2022 2:58pm
On the convert, do you think the company could just take the viewpoint that if the stock price has not ascended to $14.80 by June of next year on the back of progress on cancer that the  market begins to value, that they would just refinance it with another convert? If so, and it seems reasonable to consider that as an option assuming the worst case scenario plays out of the TH-1902 cancer ...more  
Comment by palinc2000 on Jan 15, 2022 3:47pm
The Convert was issued when Luc was guiding for 500 million $ Trog sales ....I have no idea what will entice the market to loan 55 million USD to THTX which would all be used to repay the Convert becoming due,,,,,Is there  possibility that the enticement would be based on expectations of a rising SP if Phase 1 b turns out to show much efficacy in 2 3 indications,,,,Yes of course but this is a ...more  
Comment by SPCEO1 on Jan 15, 2022 4:44pm
I would suggest that the potential for billions in cancer sales might be enough to get investors to go for a second round of converts from TH, albeit at a potentially higher interest rate due to both the lkelihood interest rates will be higher by then and due to the perceived greater risk from an early stage cancer program vs. a recently approved Trogarzo. It also helps that they have cash flow ...more  
Comment by palinc2000 on Jan 15, 2022 5:19pm
Of course it might but the Company will not wait till next year to remove that dark cloud...I dont recall ever reading about who are the Holders of the Convert and how many are there ? The terms could be changed by mutual agreement  for all or part of the Converts with all  or a few major holders .....extending the due date  for x years in exchange for a combination of higher ...more  
Comment by SPCEO1 on Jan 15, 2022 6:09pm
I don't believe the convert holders have to identify themselves. And while the idea of approaching them to roll their holdings over makes sense, I don't think that happens very often.  If they dealt with the convert sooner rather than later, I suppose that is the best outcome as it takes away any concern that things suddenly go upside down for TH in ways that no one can now imagine ...more  
Comment by palinc2000 on Jan 15, 2022 7:18pm
The main characteristics of a lottery tickets are as follows 1-Very low nominal cost of the ticket in relation to the possible winnings THTX paid next to nothing for the platform and you and others talk about multi billion sales  2-Only one winner for the top prize,,,,,many more for secondary prizes 3-Odds of winning the big prize is very high even for those using mathematical formulas that ...more  
Comment by palinc2000 on Jan 16, 2022 9:51am
US markets are closed Monday for Martin Luther King Jr Day,,,,,So a Friday night 4 PM PR was not a possibility!!!!
Comment by SPCEO1 on Jan 14, 2022 7:43pm
You can all chill out and enjoy your weekend. Chances are pretty high they will not proceed in NASH without a partner. If so, there is no reason to raise money since if they have a partner they will provide the funding and if they do not, they likely will not move forward. Maybe if cancer turns out promising and the stock price jumps, they do an offering to fund NASH, but if they enjoy their jobs, ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities